IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia

Chiung Yuan Ko, Wen Ling Wang, Chien Feng Li, Yung Ming Jeng, Yu Yi Chu, Han Ying Wang, Joseph T. Tseng, Ju Ming Wang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Acute myeloid leukemia is the majority type presented in leukemia patients. Forcing malignant cells to undergo differentiation is 1 strategy for acute myeloid leukemia therapy. However, the failure of acute myeloid leukemia patients to achieve remission as a result of drug resistance remains a challenge. In this study, we found that the abundances of the proinflammatory cytokine IL-18 and its receptor (IL-18R) correlated with the occurrence of drug resistance in AML patients during standard treatment. Cyclooxygenase 2 (COX-2) has been suggested to have an antiapoptotic role in chemoresistant cancer cells. IL-18 treatment resulted in an increase in COX-2 expression through the post-transcriptional regulation of COX-2 mRNA in differentiated U937 cells and showed antiapoptotic activity in U937 and THP-1 cells. Two RNA-binding proteins, human antigen R and insulinlike growth factor mRNA-binding protein 3, mediated the stabilization of COX-2 mRNA. IL-18 induced the shuttling of human antigen R and insulin-like growth factor mRNAbinding protein 3 from the nucleus to the cytoplasm and facilitated their interaction; subsequently, this complex bound to the 39 untranslated region of COX-2 mRNA and affected its stability. We demonstrated further that JNK and/or ERK1/2 regulated human antigen R nucleocytoplasmic shuttling, mediating IL-18 stabilization of cyclooxygenase 2 mRNA.

Original languageEnglish
Pages (from-to)131-141
Number of pages11
JournalJournal of Leukocyte Biology
Volume99
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Interleukin-18
Cyclooxygenase 2
Acute Myeloid Leukemia
Messenger RNA
Drug Resistance
Antigens
Interleukin-18 Receptors
Untranslated Regions
U937 Cells
RNA-Binding Proteins
Somatomedins
Intercellular Signaling Peptides and Proteins
Carrier Proteins
Cytoplasm
Leukemia
Therapeutics
Cytokines
Neoplasms
Proteins

Keywords

  • Differentiation therapy
  • Drug resistance
  • Post-transcriptional regulation

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia. / Ko, Chiung Yuan; Wang, Wen Ling; Li, Chien Feng; Jeng, Yung Ming; Chu, Yu Yi; Wang, Han Ying; Tseng, Joseph T.; Wang, Ju Ming.

In: Journal of Leukocyte Biology, Vol. 99, No. 1, 01.01.2016, p. 131-141.

Research output: Contribution to journalArticle

Ko, Chiung Yuan ; Wang, Wen Ling ; Li, Chien Feng ; Jeng, Yung Ming ; Chu, Yu Yi ; Wang, Han Ying ; Tseng, Joseph T. ; Wang, Ju Ming. / IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia. In: Journal of Leukocyte Biology. 2016 ; Vol. 99, No. 1. pp. 131-141.
@article{fb12b803f3014a1cbd2fae875c92b925,
title = "IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia",
abstract = "Acute myeloid leukemia is the majority type presented in leukemia patients. Forcing malignant cells to undergo differentiation is 1 strategy for acute myeloid leukemia therapy. However, the failure of acute myeloid leukemia patients to achieve remission as a result of drug resistance remains a challenge. In this study, we found that the abundances of the proinflammatory cytokine IL-18 and its receptor (IL-18R) correlated with the occurrence of drug resistance in AML patients during standard treatment. Cyclooxygenase 2 (COX-2) has been suggested to have an antiapoptotic role in chemoresistant cancer cells. IL-18 treatment resulted in an increase in COX-2 expression through the post-transcriptional regulation of COX-2 mRNA in differentiated U937 cells and showed antiapoptotic activity in U937 and THP-1 cells. Two RNA-binding proteins, human antigen R and insulinlike growth factor mRNA-binding protein 3, mediated the stabilization of COX-2 mRNA. IL-18 induced the shuttling of human antigen R and insulin-like growth factor mRNAbinding protein 3 from the nucleus to the cytoplasm and facilitated their interaction; subsequently, this complex bound to the 39 untranslated region of COX-2 mRNA and affected its stability. We demonstrated further that JNK and/or ERK1/2 regulated human antigen R nucleocytoplasmic shuttling, mediating IL-18 stabilization of cyclooxygenase 2 mRNA.",
keywords = "Differentiation therapy, Drug resistance, Post-transcriptional regulation",
author = "Ko, {Chiung Yuan} and Wang, {Wen Ling} and Li, {Chien Feng} and Jeng, {Yung Ming} and Chu, {Yu Yi} and Wang, {Han Ying} and Tseng, {Joseph T.} and Wang, {Ju Ming}",
year = "2016",
month = "1",
day = "1",
doi = "10.1189/jlb.2A0414-228RR",
language = "English",
volume = "99",
pages = "131--141",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "1",

}

TY - JOUR

T1 - IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia

AU - Ko, Chiung Yuan

AU - Wang, Wen Ling

AU - Li, Chien Feng

AU - Jeng, Yung Ming

AU - Chu, Yu Yi

AU - Wang, Han Ying

AU - Tseng, Joseph T.

AU - Wang, Ju Ming

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Acute myeloid leukemia is the majority type presented in leukemia patients. Forcing malignant cells to undergo differentiation is 1 strategy for acute myeloid leukemia therapy. However, the failure of acute myeloid leukemia patients to achieve remission as a result of drug resistance remains a challenge. In this study, we found that the abundances of the proinflammatory cytokine IL-18 and its receptor (IL-18R) correlated with the occurrence of drug resistance in AML patients during standard treatment. Cyclooxygenase 2 (COX-2) has been suggested to have an antiapoptotic role in chemoresistant cancer cells. IL-18 treatment resulted in an increase in COX-2 expression through the post-transcriptional regulation of COX-2 mRNA in differentiated U937 cells and showed antiapoptotic activity in U937 and THP-1 cells. Two RNA-binding proteins, human antigen R and insulinlike growth factor mRNA-binding protein 3, mediated the stabilization of COX-2 mRNA. IL-18 induced the shuttling of human antigen R and insulin-like growth factor mRNAbinding protein 3 from the nucleus to the cytoplasm and facilitated their interaction; subsequently, this complex bound to the 39 untranslated region of COX-2 mRNA and affected its stability. We demonstrated further that JNK and/or ERK1/2 regulated human antigen R nucleocytoplasmic shuttling, mediating IL-18 stabilization of cyclooxygenase 2 mRNA.

AB - Acute myeloid leukemia is the majority type presented in leukemia patients. Forcing malignant cells to undergo differentiation is 1 strategy for acute myeloid leukemia therapy. However, the failure of acute myeloid leukemia patients to achieve remission as a result of drug resistance remains a challenge. In this study, we found that the abundances of the proinflammatory cytokine IL-18 and its receptor (IL-18R) correlated with the occurrence of drug resistance in AML patients during standard treatment. Cyclooxygenase 2 (COX-2) has been suggested to have an antiapoptotic role in chemoresistant cancer cells. IL-18 treatment resulted in an increase in COX-2 expression through the post-transcriptional regulation of COX-2 mRNA in differentiated U937 cells and showed antiapoptotic activity in U937 and THP-1 cells. Two RNA-binding proteins, human antigen R and insulinlike growth factor mRNA-binding protein 3, mediated the stabilization of COX-2 mRNA. IL-18 induced the shuttling of human antigen R and insulin-like growth factor mRNAbinding protein 3 from the nucleus to the cytoplasm and facilitated their interaction; subsequently, this complex bound to the 39 untranslated region of COX-2 mRNA and affected its stability. We demonstrated further that JNK and/or ERK1/2 regulated human antigen R nucleocytoplasmic shuttling, mediating IL-18 stabilization of cyclooxygenase 2 mRNA.

KW - Differentiation therapy

KW - Drug resistance

KW - Post-transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=84953439694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953439694&partnerID=8YFLogxK

U2 - 10.1189/jlb.2A0414-228RR

DO - 10.1189/jlb.2A0414-228RR

M3 - Article

C2 - 26342105

AN - SCOPUS:84953439694

VL - 99

SP - 131

EP - 141

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 1

ER -